NASDAQ:FATE Investor Alert: Investigation over Potential Wrongdoing at Fate Therapeutics, Inc
An investigation was announced for investors in shares of Fate Therapeutics, Inc. (NASDAQ: FATE) concerning potential breaches of fiduciary duties by certain officers and directors at Fate Therapeutics, Inc.
View full press release